Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

The donation matching program is part of Regeneron's broader commitment to improving patient outcomes and supporting healthcare access.

These explorations could look at specific programs that use PAPs to improve patient health, and they could compare overall drug spending and staff resources used by safety-net clinics whose ...

A federal appeals court’s recent ruling could cost the Pension Benefit Guaranty Corp.’s Special Financial Assistance program another $6 billion, according to a risk advisory from the agency ...

Patient-Assistance Programs: Assessment of and Use by Safety-Net Clinics Kathryn Saenz Duke; Kristiana Raube; Helene Levens Lipton Disclosures Am J Health Syst Pharm. 2005;62 (7):726-731. Methods ...

Suneet Varma, Global Oncology & U.S. President at Pfizer, tells SurvivorNet that the company aims to continue making progress related to improving cancer screening rates by leveraging technology ...

Biodexa is developing Tolimidone to treat type 1 diabetes and has recently enrolled its first patient in a phase 2a trial. Tolimidone was first discovered by Pfizer Inc.

We interviewed experts in the field of pediatric rheumatology to understand gaps in juvenile idiopathic arthritis management.

Patient assistance programs Pharmaceutical companies, nonprofits, and government agencies offer patient assistance programs. These provide free or discounted prescription medications.